Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides for inhibition of PD-L1 expression and treating cancer

Antisense oligonucleotides for inhibition of PD-L1 expression and treating cancer

US Patent 11666595 · Granted Jun 6, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2024
Immunosuppression-reverting oligonucleotides inhibiting the expression of CD392024
Immunosuppression-reverting oligonucleotides inhibiting the expression of CD392024
Oligonucleotide inhibiting the expression of Chop2023
Oligonucleotide inhibiting the expression of Chop2023
ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2023
Approach for treating inflammatory disorders2020
Modified TGF-beta oligonucleotides2020
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2018
Modified TGF-beta oligonucleotides2018
Modified TGF-beta2 oligonucleotides2017
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2017